Showing results (171-180 of 6,999) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|February 3, 2022
Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumoniaMariko Fukui, Kazuhiro Suzuki, Katsutoshi Ando, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experienceMark G Faber, Chong Wang, Sruthi Kommi Reddy, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2022
Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomesJianrong Zhang, Maarten J IJzerman, Jasmeen Oberoi, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2022
Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancerMonica Tang, Chee K Lee, Craig R Lewis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 24, 2021
Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?Julie Niogret, Lorraine Dalens, Caroline Truntzer, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancerWanyuan Cui, Charlotte Milner-Watts, Terri P McVeigh, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2022
Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancerChang Liu, Cuicui Liu, Jiatao Liao, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2022
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trialPenella Woll, Piers Gaunt, Sarah Danson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 21, 2022
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitisTakeya Sugimoto, Daichi Fujimoto, Yuki Sato, et al.
Lung Cancer (Amsterdam, Netherlands)|April 4, 2022
Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancerSofie Claerhout, Stefan Lehnert, Sara Vander Borght, et al.
Pageof 700